Experimental Assessment of Absorbed Doses in Pathological Lesions during Radionuclide Therapy with 225Ac-PSMA-617 and 225Ac-DOTATATE

Author:

Chipiga L. A.1,Lavreshov D. D.2,Vodovatov A. V.3,Parunova E. N.2,Zvonova I. A.4,Petryakova A. V.5,Vazhenina D. A.6,Odintsova M. V.6,Nomokonova V. B.6,Stanzhevsky A. A.7,Maistrenko D. N.7

Affiliation:

1. P.V. Ramzaev Saint-Petersburg Research Institute of Radiation Hygiene;;A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies; Saint-Petersburg State Pediatric Medical University

2. Peter the Great St. Petersburg Polytechnic University

3. P.V. Ramzaev Saint-Petersburg Research Institute of Radiation Hygiene; V.A. Almazov National Medical Research Centre

4. P.V. Ramzaev Saint-Petersburg Research Institute of Radiation Hygiene

5. P.V. Ramzaev Saint-Petersburg Research Institute of Radiation Hygiene; The City Hospital No 40 of the Kurortny District

6. A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies

7. Saint-Petersburg State Pediatric Medical University

Abstract

Development of radiopharmaceutical therapy treatment plans considering biokinetics of radiopharmaceuticals and individual features of patients is necessary for the provision of radiation safety of the patients and increase in the efficacy of treatment. Hence, it is necessary to assess the absorbed doses in lesions (targets). The current study presents the method for the assessment of the absorbed doses in lesions considering the biological effectiveness of exposure for the radiopharmaceutical therapy with 225Ac-PSMA-617 and 225Ac-DOTATATE. Assessment of the absorbed doses was performed based on the analysis of the PET images of patients. Results of the study indicate that the absorbed doses for 225Ac-PSMA-617 and 225Ac-DOTATATE were in the range of 90-190 Gy-eq. and 30-500 Gy-eq. correspondingly. The lack of radiotoxicity and accumulation of required absorbed dose per treatment course indicates the efficiency of radiopharmaceutical therapy with 225Ac-PSMA-617 and 225Ac-DOTATATE.

Publisher

Association of Medical Physicists in Russia

Reference26 articles.

1. Sgouros G, Bolch WE, Chiti A, et al. ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy. Journal of the ICRU. 2021; 21 (1): 1-212.

2. Gleisner KS, Chouin N, Gabina PM, et al. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands. Eur J Nucl Med Mol Imaging. 2022 May; 49 (6): 1778-809. DOI: 10.1007/s00259-022-05727-7.

3. Наркевич БЯ, Крылов АС, Рыжков АД, Гелиашвили ТМ. Дозиметрическое сопровождение радионуклидной терапии. Онкологический журнал: лучевая диагностика, лучевая терапия. 2023; 6 (2): 66-84 [Narkevich BYa, Krylov AS, Ryzhkov AD, Geliashvili TM. Dosimetric Support of Radionuclide Therapy. Journal of Oncology: Diagnostic Radiology and Radiotherapy. 2023; 6 (2): 66-84. (In Russian)].

4. Наркевич БЯ, Крылов АС, Рыжков АД. Упрощенный способ расчета доз внутреннего облучения костных метастазов при радионуклидной терапии. Медицинская физика. 2023; (1): 43-54 [Narkevich BYa, Krylov AS, Ryzhkov AD. Simplified method for calculation of internal exposure dose to bone metastases during radionuclide therapy. Medical physics. 2023; (1): 43-54 (In Russian)].

5. Станжевский АА, Майстренко ДН, Важенина ДА, Сысоев ДС, Водоватов АВ, Чипига ЛА, Рыжов СА, Петрякова АВ. Методы дозиметрического планирования в радионуклидной терапии. Часть 2: Уровни планирования. Лучевая диагностика и терапия. 2022; 13 (4): 16-26 [Stanzhevskii AA, Maistrenko DN, Vazhenina DA, Sysoev DS, Vodovatov AV, Chipiga LA, Ryzhov SA, Petryakova AV. Methods of dosimetry-based treatment planning in radiopharmaceutical therapy. Part 2: Planning levels. Diagnostic radiology and radiotherapy. 2022; 13 (4): 16-26. (In Russian)].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3